---
title: "AbbVie Declares Quarterly Dividend | ABBV Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298632359.md"
description: "AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $1.73 per share, payable on November 16, 2026, to shareholders of record as of October 15, 2026. Since its inception in 2013, AbbVie has increased its dividend by over 330 percent and is a member of the S&P Dividend Aristocrats Index."
datetime: "2026-09-10T10:17:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298632359.md)
  - [en](https://longbridge.com/en/news/298632359.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298632359.md)
generator: "portal-rs"
---

# AbbVie Declares Quarterly Dividend | ABBV Stock News

AbbVie (ABBV) declared a quarterly cash dividend of $1.73 per share, payable on November 16, 2026, to shareholders of record as of October 15, 2026.

, /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share. 

The cash dividend is payable November 16, 2026, to stockholders of record at the close of business on October 15, 2026.

Since the company's inception in 2013, AbbVie has increased its dividend by more than 330 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

**About AbbVie**

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

**Media:** 

**Investors:**

Catherine Langel

Liz Shea

(708) 508-3524 

(847) 935-2211

catherine.langel@abbvie.com

liz.shea@abbvie.com

SOURCE AbbVie

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [ADARx Pharmaceuticals Prices IPO Of 21.875 Mln Shares Between $15.00 And $17.00/Share](https://longbridge.com/en/news/299652402.md)
- [AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now?](https://longbridge.com/en/news/299532734.md)
- [Michael Saylor Says, 'A Little More Orange': Will Strategy Report BTC Purchases After Hitting Pause for 3 Weeks?](https://longbridge.com/en/news/299601303.md)
- [Prediction: Berkshire Hathaway's Operating Earnings Will Top $48 Billion in 2026](https://longbridge.com/en/news/299668979.md)
- [Greenland Resources eyes US exchange listing after US-Denmark deal](https://longbridge.com/en/news/299663759.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**